Media Coverage

Epidermolysis Bullosa News
Media Coverage

November 11, 2020

Epidermolysis Bullosa News

1st Patient Treated in Phase 3 Trial of RDEB Gene Therapy, D-Fi

Read More
Media Coverage

October 29, 2020

Cell & Gene

Castle Creek Biosciences’ D-Fi To Be Manufactured At In-House cGMP

Read More
Media Coverage

October 20, 2020

Scleroderma News

First Patient Treated in Trial Testing FCX-013 Gene Therapy for Localized Scleroderma

Read More
Media Coverage

May 09, 2020

Philadelphia Magazine’s NextHealth PHL

9 Philly Companies on the Cutting Edge of Cell and Gene Therapy Innovation

Read More
Media Coverage

February 29, 2020

Philadelphia Magazine’s NextHealth PHL

NextUp: “The Company Using Gene Therapy to Cure Rare Skin Conditions” John Maslowski, CEO, Castle Creek Biosciences

Read More
Media Coverage

January 02, 2020

Rare Daily’s RARECast

“Acquisition Combines Two Pipelines for Rare Skin Diseases” John Maslowski, CEO, Castle Creek Biosciences

Read More